Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2835 (LINC02835)

Target
LINC02835
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-protein coding RNA (lincRNA), Retrotransposon-derived lncRNA, Other
01

Overview

Long intergenic non-protein coding RNA 2835 (LINC02835), also known as lncMER52A, is a long non-coding RNA (lncRNA) of more than 200 nucleotides, specifically identified as an oncogenic RNA in liver cancer. It is transcribed from a MER52A LTR retrotransposon of the ERV1 class, and functions independently of protein coding, primarily through regulatory interactions with chromatin, transcriptional machinery, and potentially as a molecular scaffold or guide for protein complexes involved in gene expression regulation. LncRNAs like LINC02835 are notable for their diverse mechanisms that include both cis and trans regulatory effects, context-specific functions, and roles in disease, particularly as cancer drivers or suppressors. The functional and structural plasticity of lncRNAs, sequence diversity, and frequent lack of sequence conservation complicate both biological understanding and therapeutic targeting. As of now, there are no approved drugs or clinical biomarkers directly associated with LINC02835.

Other names
lncMER52ALiver cancer-specific oncogenic long non-coding RNA transcribed by MER52A LTR retrotransposon of the ERV1 class
02

Biological functions

Regulation of gene transcriptionEpigenetic regulationPotential oncogenic role in liver cancerPossibly acts as molecular scaffold, decoy, or guide for regulatory complexes
03

Disease associations

Cancer (specifically liver cancer; described as an oncogenic lncRNA)Other (lncRNAs broadly associated with diverse disease processes, but primary described role for LINC02835 is oncogenic in liver cancer)
04

Safety considerations

Targeting lncRNAs can risk off-target effects due to sequence and structure redundancyLack of evolutionary conservation complicates prediction of safety profile and essential functions

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2835 (LINC02835).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2835 (LINC02835).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call